Clinical Trial Update: CCRT for Esophageal Cancer. [Phase 2]

View source ↗

Summary

The document announces completion of a Phase 2 trial of concurrent chemoradiotherapy for esophageal cancer, involving oxaliplatin and paclitaxel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hangzhou Cancer Hospital | Conditions: Esophageal Cancer, Concurrent Chemoradiotherapy | Phase 2 | Status: COMPLETED